Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2012

Open Access 01-12-2012 | Case report

Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report

Authors: Karim Gariani, Sophie de Seigneux, Marie Courbebaisse, Marc Lévy, Solange Moll, Pierre-Yves Martin

Published in: Journal of Medical Case Reports | Issue 1/2012

Login to get access

Abstract

Introduction

Oxalate nephropathy has various etiologies and remains a rare cause of renal failure. To the best of our knowledge, we report the first case of oxalate nephropathy following octreotide therapy.

Case presentation

We report the case of a 78-year-old Caucasian man taking chronic octreotide treatment for acromegaly who presented with acute oxalate nephropathy after antibiotic therapy. The diagnosis was confirmed by urinary analysis and a kidney biopsy. The recovery of renal function was favorable after hydration and withdrawal of octreotide therapy.

Conclusions

Oxalate nephropathy should be suspected in patients at risk who present with acute kidney injury after prolonged antibiotic treatment. This diagnosis should be distinguished from immuno-allergic interstitial nephritis and requires specific care. The evolution of this condition may be favorable if the pathology is identified correctly. Octreotide therapy should be considered a risk factor for enteric oxaluria.
Appendix
Available only for authorised users
Literature
2.
go back to reference Cartery C, Faquer S, Karras A, Cointault O, Buscail L, Modesto A, Ribes D, Rostaing L, Chauveau D, Giraud P: Oxalate nephropathy associated with chronic pancreatitis. Clin J Am Soc Nephrol. 2011, 6: 1895-1902. 10.2215/CJN.00010111.CrossRefPubMedPubMedCentral Cartery C, Faquer S, Karras A, Cointault O, Buscail L, Modesto A, Ribes D, Rostaing L, Chauveau D, Giraud P: Oxalate nephropathy associated with chronic pancreatitis. Clin J Am Soc Nephrol. 2011, 6: 1895-1902. 10.2215/CJN.00010111.CrossRefPubMedPubMedCentral
3.
go back to reference Nasr SH, D’Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, Markowitz GS: Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008, 2: 1676-1683.CrossRef Nasr SH, D’Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, Markowitz GS: Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008, 2: 1676-1683.CrossRef
4.
go back to reference Nasr SH, Kashtanova Y, Levchuk V, Markowitz GS: Secondary oxalosis due to excess vitamin C intake. Kidney Int. 2006, 70: 1672-10.1038/sj.ki.5001724.CrossRefPubMed Nasr SH, Kashtanova Y, Levchuk V, Markowitz GS: Secondary oxalosis due to excess vitamin C intake. Kidney Int. 2006, 70: 1672-10.1038/sj.ki.5001724.CrossRefPubMed
5.
go back to reference McKeage K, Cheer S, Wagstaff AJ: Octreotide long-acting release (LAR): a review of its use in the management of acromegaly. Drugs. 2003, 63: 2473-2499. 10.2165/00003495-200363220-00014.CrossRefPubMed McKeage K, Cheer S, Wagstaff AJ: Octreotide long-acting release (LAR): a review of its use in the management of acromegaly. Drugs. 2003, 63: 2473-2499. 10.2165/00003495-200363220-00014.CrossRefPubMed
6.
go back to reference Stauffer JQ: Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Am J Dig Dis. 1977, 22: 921-928. 10.1007/BF01076170.CrossRefPubMed Stauffer JQ: Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Am J Dig Dis. 1977, 22: 921-928. 10.1007/BF01076170.CrossRefPubMed
7.
go back to reference Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB: Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet. 1998, 352: 1026-1029. 10.1016/S0140-6736(98)03038-4.CrossRefPubMed Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB: Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet. 1998, 352: 1026-1029. 10.1016/S0140-6736(98)03038-4.CrossRefPubMed
8.
go back to reference Mittal RD, Kumar R, Bid HK, Mittal B: Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol. 2005, 19: 102-106. 10.1089/end.2005.19.102.CrossRefPubMed Mittal RD, Kumar R, Bid HK, Mittal B: Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol. 2005, 19: 102-106. 10.1089/end.2005.19.102.CrossRefPubMed
9.
go back to reference Lefaucheur C, Hill GS, Amrein C, Haymann JP, Jacquot C, Glotz D, Nochy D: Acute oxalate nephropathy: a new etiology for acute renal failure following nonrenal solid organ transplantation. Am J Transplant. 2006, 6: 2516-2521. 10.1111/j.1600-6143.2006.01485.x.CrossRefPubMed Lefaucheur C, Hill GS, Amrein C, Haymann JP, Jacquot C, Glotz D, Nochy D: Acute oxalate nephropathy: a new etiology for acute renal failure following nonrenal solid organ transplantation. Am J Transplant. 2006, 6: 2516-2521. 10.1111/j.1600-6143.2006.01485.x.CrossRefPubMed
Metadata
Title
Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
Authors
Karim Gariani
Sophie de Seigneux
Marie Courbebaisse
Marc Lévy
Solange Moll
Pierre-Yves Martin
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2012
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-6-215

Other articles of this Issue 1/2012

Journal of Medical Case Reports 1/2012 Go to the issue